4//SEC Filing
Zubretsky Joseph M 4
Accession 0001179929-22-000167
CIK 0001179929other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:27 PM ET
Size
53.4 KB
Accession
0001179929-22-000167
Insider Transaction Report
Form 4
Zubretsky Joseph M
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2022-10-05$348.62/sh−7,265$2,532,701→ 267,638 total - Exercise/Conversion
Common Stock
2022-10-06$67.33/sh+30,000$2,019,900→ 285,157 total - Sale
Common Stock
2022-10-06$352.61/sh−2,231$786,676→ 282,926 total - Sale
Common Stock
2022-10-06$356.32/sh−2,700$962,065→ 255,157 total - Sale
Common Stock
2022-10-07$348.24/sh−5,403$1,881,533→ 256,569 total - Sale
Common Stock
2022-10-06$353.70/sh−5,669$2,005,124→ 277,257 total - Sale
Common Stock
2022-10-06$355.49/sh−9,977$3,546,679→ 257,857 total - Sale
Common Stock
2022-10-07$347.23/sh−6,031$2,094,124→ 261,972 total - Exercise/Conversion
Common Stock
2022-10-05$67.33/sh+30,000$2,019,900→ 285,157 total - Sale
Common Stock
2022-10-05$350.60/sh−3,114$1,091,759→ 259,258 total - Sale
Common Stock
2022-10-05$352.83/sh−1,444$509,488→ 255,157 total - Sale
Common Stock
2022-10-06$354.61/sh−9,423$3,341,518→ 267,834 total - Sale
Common Stock
2022-10-07$346.16/sh−8,137$2,816,690→ 268,003 total - Sale
Common Stock
2022-10-07$348.85/sh−1,412$492,576→ 255,157 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-10-05−30,000→ 58,914 totalExercise: $67.33Exp: 2027-10-08→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-10-06−30,000→ 28,914 totalExercise: $67.33Exp: 2027-10-08→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-10-07−28,914→ 0 totalExercise: $67.33Exp: 2027-10-08→ Common Stock (28,914 underlying) - Sale
Common Stock
2022-10-05$347.70/sh−3,123$1,085,852→ 274,903 total - Sale
Common Stock
2022-10-05$349.50/sh−5,266$1,840,462→ 262,372 total - Sale
Common Stock
2022-10-05$345.73/sh−2,931$1,013,349→ 282,226 total - Sale
Common Stock
2022-10-05$346.71/sh−4,200$1,456,203→ 278,026 total - Sale
Common Stock
2022-10-05$351.73/sh−2,657$934,538→ 256,601 total - Exercise/Conversion
Common Stock
2022-10-07$67.33/sh+28,914$1,946,780→ 284,071 total - Sale
Common Stock
2022-10-07$342.95/sh−1,105$378,963→ 282,966 total - Sale
Common Stock
2022-10-07$344.32/sh−2,323$799,847→ 280,643 total - Sale
Common Stock
2022-10-07$345.20/sh−4,503$1,554,426→ 276,140 total
Footnotes (23)
- [F1]As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan.
- [F10]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $352.13 to $353.12. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F11]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $353.13 to $354.10. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F12]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $354.13 to $355.11. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F13]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $355.13 to $356.11. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F14]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $356.15 to $356.67. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F15]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.52 to $343.39. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F16]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.68 to $344.67. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F17]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $344.70 to $345.63. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F18]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.71 to $346.69. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F19]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.72 to $347.71. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.11 to $345.95. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F20]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.73 to $348.71. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F21]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $348.73 to $349.14. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F22]30,372 shares vest on March 1, 2023; 15,412 shares vest on March 1, 2024; 6,412 shares vest on March 1, 2025. The remainder of the shares are vested.
- [F23]The options are fully vested.
- [F3]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.11 to $347.10. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F4]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.11 to $348.08. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F5]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $348.15 to $349.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F6]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $349.15 to $350.12. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F7]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $350.20 to $350.95. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F8]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $351.25 to $352.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F9]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $352.54 to $352.99. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Issuer
MOLINA HEALTHCARE, INC.
CIK 0001179929
Entity typeother
Related Parties
1- filerCIK 0001320929
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 7:27 PM ET
- Size
- 53.4 KB